Lymphangioleiomyomatosis

Also known as: Lymphangiomyomatosis

DrugDrug NameDrug Description
DB00877SirolimusAn immunosuppressant used to prevent organ transplant rejections and to treat lymphangioleiomyomatosis.
DrugDrug NamePhaseStatusCount
DB00112Bevacizumab1Recruiting1
DB00002Cetuximab1Recruiting1
DB01611Hydroxychloroquine1Completed1
DB00825Levomenthol1Recruiting1
DB00877Sirolimus1Completed1
DB00877Sirolimus1Recruiting1
DB06287Temsirolimus1Recruiting1
DB00313Valproic acid1Recruiting1
DB01590Everolimus1 / 2Completed1
DB00619Imatinib1 / 2Completed1
DB00641Simvastatin1 / 2Active Not Recruiting1
DB01590Everolimus2Completed1
DB01006Letrozole2Completed1
DB09079Nintedanib2Recruiting1
DB00104Octreotide2Completed1
DB02709Resveratrol2Recruiting1
DB01001Salbutamol2Recruiting1
DB00877Sirolimus2Completed1
DB00877Sirolimus2Recruiting1
DB00877Sirolimus2Unknown Status1
DB00877Sirolimus3Recruiting1
DB00877Sirolimus3Unknown Status1
DB00254Doxycycline4Completed1
DB01590EverolimusNot AvailableActive Not Recruiting1
DB00877SirolimusNot AvailableActive Not Recruiting1